I just noticed that more and more people are becoming interested in investing in hospital stocks— and that makes sense, because this industry is stable and delivers consistent returns, unlike other stocks that can be volatile day to day.



In fact, investing in hospitals is considered choosing a defensive stock. Because medical services are necessary and not dependent on economic conditions, this sector has stable income and can still grow even when the market is not good.

Let’s take a look at which hospital stocks in 2569 (2026) are worth keeping an eye on. BDMS stands out with its hospital network spread both in and abroad. Market Cap is 319,430 million baht. The stock price is 20 baht. P/E is 19.5x. ROE is 16.8%. The company has plans to expand its international customer base and increase the number of beds, which should lead to continued profit growth.

Another interesting one is BH, with a Market Cap of 135,060 million baht and a price of 167.50 baht. This hospital has a high proportion of foreign patients. ROE is as high as 31.9%, which is a very good figure for using capital. The company is adjusting service prices and expanding its facilities to accommodate a growing number of foreign patients.

For those who prefer low risk and regular income, BCH is also a good option. Even though its Market Cap is 25,190 million baht, the company has a stable operating track record. The price is 10.20 baht, P/E is 19.7x, and profits are expected to grow 23% this year.

RAM is a well-known hospital specializing in treatments for specific conditions—especially heart disease and surgery. It is located on Ramkhamhaeng Road, an area with high population density. The price is 18.20 baht. Even though ROE is low, a P/E of 33.41 indicates that the market expects growth.

VIBHA is one to watch, with a Market Cap of 18,470 million baht and a price of 1.88 baht. Analysts recommend buying it, setting a target price of 2.74 baht. They believe this year’s outlook looks good thanks to eased concerns about the Social Security Office.

CHG and PR9 are mid-sized hospitals with growth potential. CHG has a Market Cap of 17,270 million baht and a price of 1.50 baht. Meanwhile, PR9 has a Market Cap of 14,940 million baht and a price of 18.7–18.9 baht. Both have plans to expand branches and increase the number of beds.

When it comes to choosing hospital stocks, you need to look at what type of customers each hospital focuses on. Some emphasize foreign patients, while others focus on Thai patients and Social Security. This is very important because it affects the stability of revenue.

You should also study the PE and ROE figures carefully. PE helps you understand how the profits the company generates compare with the stock price. ROE shows how efficiently the company uses shareholders’ capital.

The reason hospital stocks are attractive is that the population is increasing, society is entering an aging era, and demand for medical services with higher standards is rising—creating opportunities for ongoing business growth.

For investors who are looking for dividend-paying stocks with steady income, this group of hospital stocks should fit the bill well. The nature of this business is that you invest once, and then cash flow continues to come in steadily—unlike other businesses that need ongoing reinvestment.

If you’re interested in hospital stocks whose customer base is mainly foreign, you should look at BDMS or BH. If you want low risk and stocks suitable for long-term holding, consider mid-sized names such as VIBHA, CHG, or PR9, which have potential to expand.

Remember that investing in hospital stocks should be done carefully. Study the fundamentals, keep up with news and analyst recommendations, and invest with a long-term perspective to achieve good returns. If you want to enhance the stability of your portfolio, considering these 7 hospital stocks is definitely worth it.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments